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New Zealand  Black  (NZB) ]  mice spontaneously develop autoimmune hemolytic 
anemia,  excessive  lymphoproliferation,  and  immune-complex deposition  (1-4).  In 
addition  to  anti-erythrocyte  autoantibodies,  NZB  mice  produce  autoantibodies  to 
nucleic acids and to T  lymphocytes (4-7).  Although  the mechanism responsible for 
the spontaneous  autoimmune disease remains unknown,  evidence has accumulated 
that suggests that NZB B lymphocytes are spontaneously activated very early in life, 
before  the  appearance of detectable  serum  autoantibodies.  Spleen  cells  from  very 
young NZB mice have been shown to contain an abnormally high proportion of cells 
spontaneously producing antibody to several synthetic haptens (8-10)  and to secrete 
excessive amounts  of pentameric  IgM  in  culture  (11).  NZB  B  lymphocyte surface 
membranes bear an abnormally low proportion of IgD relative to IgM (12,  13);  this 
pattern  is  characteristic  of mitogenically  (14)  or  antigenically  (10)  stimulated  B 
lymphocytes  from  mice  of  nonautoimmune  strains.  Young  NZB  mice  make  an 
abnormally large antibody response to sheep erythrocytes (SRBC)  (15,  16),  and are 
abnormally resistant to tolerance induction  (17,  18). The role of T  lymphocytes in the 
development of the B  lymphocyte hyperactivity of NZB  mice is unclear.  Although 
considerable  evidence  points  to  T-cell  abnormalities  in  NZB  mice  (19-26),  other 
evidence suggests that the B-cell hyperactivity begins early in life in the absence ofT- 
cell influence (10-12, 27, 28). 
CBA/N mice bear an X-chromosome-linked defect in the immune response to T- 
independent  antigens  such  as  pneumococcal  polysaccharide  (29),  polyinosinic. 
polycytidylic acid  (rI-rC)  (30),  and  haptenated  Ficoll  derivatives  (31).  All  CBA/N 
mice and  the  F1  male offspring of CBA/N  females are thus  affected.  The CBA/N 
defect  is associated with  low serum  IgM levels  (32),  reduced  numbers of splenic  B 
cells, and a  paucity of B cells with a  low density of surface-membrane IgM (33, 34). 
In contrast, the response of CBA/N mice to T-dependent antigens is relatively normal 
(35), as are CBA/N serum IgG levels (32). 
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F1 hybrids of NZB mice, particularly NZB  X  New Zealand White (NZB  X  NZW), 
but also NZB  X  BALB/c, NZB  X  DBA/2, and C3H  X  NZB share some autoimmune 
features  with  NZB  mice  (3,  7,  17,  36).  Evidence  has  accumulated  that  male  sex 
hormones  retard the expression of autoimmune  disease in NZB  F1  hybrids  (37-40). 
To gain insight into the role ofT-independent immune responses in the autoimmune 
disease of NZB mice and their hybrids, we have undertaken a  series of investigations 
of CBA/N  ×  NZB mice. To ensure that chromosomal rather than hormonal effects 
would  account  for differences observed between  CBA/N  X  NZB  male and  female 
mice, and  to  minimize the  effect  of androgens  on  immune  phenomena  of NZB  Fx 
hybrid males, all mice used  in  these studies were prepubertally castrated.  We have 
found that the CBA/N  X-linked B-cell defect is fully expressed in CBA/N  X  NZB F1 
male mice. 
Materials  and  Methods 
Mice.  All F1  hybrid mice are designated by the  maternal  strain first. CBA/N,  NZB/N, 
CBA/N  X  NZB,  NZB  X  CBA/N, C3H/HeN  X  NZB,  BALB/c  X  NZB,  and CBA/N  X 
DBA/2 mice were obtained from the animal productions facilities of the National Institutes of 
Health. CBA/J mice, obtained from the Jackson Laboratory, Bar Harbor, Maine, served as 
normal controls for CBA/N  mice and the various F1 hybrids. CBA/J  X  NZB/N  mice were 
bred in our laboratory. 
Surgical Procedures.  All mice, except as noted,  underwent  surgical castration under  ether 
anesthesia at  3-4 wk of age. Testes were removed through either a  scrotal or an abdominal 
incision; ovaries were removed through bilateral flank incisions. Incisions were closed with 6-0 
silk sutures. Identical incisions were made in sham-castrated animals, but the gonads were left 
intact. 
Spleen Cell Preparation.  Each mouse was killed by cervical dislocation and its spleen removed 
and placed in 10 ml of chilled Eagle's minimal essential medium (Grand Island Biological Co., 
Grand Island, N. Y.) containing 1% nonessential amino acids; 2 mM glutamine; 15 mM Hepes, 
pH  7.2;  6  pg/ml  penicillin; 25  pg/ml  gentamicin;  and  2%  fetal calf serum  (Grand  Island 
Biological Co.).  A  single-cell suspension was prepared by repeated passage of teased spleen 
through a 25-gauge needle, and the cells were washed in the same medium. 
In most experiments, cells from individual spleens were simultaneously assayed for sponta- 
neous in vitro IgM secretion and for subclass-specific Ig-producing cells. In some experiments, 
cells were also simultaneously analyzed by flow microfluorometry for surface- and cytoplasmic- 
Ig characteristics. 
Spleen Cell Cultures.  The washed cells from each spleen were centrifuged three times through 
fetal calf serum at 400 g for 5 min, resuspended at 1.0 X  10  7 cells/ml in the medium described 
above, and cultured in a 65-mm plastic Petri dish (Falcon Labware, Div. of Becton, Dickinson 
& Co., Oxnard, Calif.)  for 4  h  at  37°C  in a  humidified atmosphere containing 5%  CO2.  A 
baseline sample of each cell supernate obtained before culture was assayed for IgM along with 
a sample of the 4-h-culture supernate. Viability of the cells immediately before culture was 80- 
92% as measured by trypan blue exclusion. 
Immunoradiornetric Assay of IgM.  The assay method previously described (11) was used, with 
two modifications. In the first modification, a 96-well microtiter plate (Cooke Engineering Co., 
Alexandria, Va.) coated with affinity purified-rabbit-anti-mouse Fab was substituted for the 
previously described anti-IgM coated beads. In the second modification, both the incubation 
of the IgM-containing sample with the microtiter plate, and the subsequent incubation of 125I- 
labeled anti-IgM with the mierotiter plate, were shortened from the previously described 4 h, 
to  1 h at room temperature. The plates were washed after each incubation, and, finally, each 
well counted  in  a  gamma  spectrometer (Beckman  Instruments,  Inc.,  Fullerton, Calif.). All 
manipulations were performed in 0.01  M  phosphate-buffered saline, pH  7.6; containing 0.01 
M  EDTA, 0.015 M  sodium azide, 0.1% Triton X-100 and 0.2% bovine serum albumin. 
Assay for Immunoglobulin-Secreting Cells.  Total subclass-specific Ig-seereting cells per spleen 
were enumerated by the reverse hemolytic-plaque method of Molinaro and Dray (41).  Briefly, TAUROG, MOUTSOPOULOS,  ROSENBERG, CHUSED,  AND STEINBERG  33 
SRBC, to which sheep anti-mouse Ig had been coupled, served as targets, while subclass-specific 
rabbit anti-mouse-Ig reagents (the gift  of Dr.  Richard Asofsky, National Institute of Allergy 
and Infectious Diseases, National Institutes of Health, Bethesda, Md.) served as developers. All 
assays were performed using the Cunningham  and Szenberg modification (42) of the hemolytic- 
plaque assay. 
Antibody Response to rI.rC.  Castrated mice were injected intraperitoneally with rI.rC (P-L 
Biochemicals, Inc., Milwaukee, Wis.), 100 #g in saline without adjuvant; they were bled 4 d 
later by retroorbital sinus puncture, and the serum was  assayed  for  antibody to  rI.rC  as 
previously described  (43).  Briefly,  25  or  50 #1  serum was  incubated overnight with  28  ng 
[a4c]rI.rC (1.8 nCi/#g, Miles Laboratories, Inc., Kankakee, Ill.); ammonium sulfate was then 
added to make a 35% saturation, and radioactivity counted in both supernate and precipitate 
in a  liquid scintillation counter (Nuclear Chicago Corp., subsid, of G. D.  Searle & Co.,  Des 
Plaines, Ill.). 
This 4-d antibody response to rI.rC, given without protein carrier or adjuvant, has been 
previously shown to be almost completely of the IgM class  (43) and to be absent in CBA/N 
mice and the F1 male offspring of CBA/N females (30). 
Immune Response to Pneumococcal Polysaccharide Type III (SIII).  Castrated mice were injected 
intraperitoneally with 0.5 #g of SIII (the gift of Dr. P. J. Baker,  National Institute of Allergy 
and  Infectious Diseases,  National  Institutes of  Health,  Bethesda,  Md.)  in  saline without 
adjuvant. 5 d later, their spleens were removed and cells forming direct hemolytic plaques in a 
slide  assay  employing SIII-coated  SRBC  were  counted.  Net  plaques  were  calculated  by 
subtracting background plaques obtained using plain SRBC. 
Flow Microfluoromet~.  To study B-cell surface-membrane-Ig  characteristics, spleen cells were 
depleted of erythrocytes by ammonium chloride lysis, then suspended at 5.0  ×  10  v cells/ml in 
Hanks' balanced salt solution containing  3 mM sodium azide and 0.1% bovine serum albumin. 
0.1-ml aliquots of the cell suspensions were incubated for 30 min with fluoresceinated F(ab)2' 
fragments of affinity purified-goat-anti-mouse Fab  (F1  anti-Fab) or anti-mouse #-chain (F1 
anti-#). The cells were then washed twice and subsequently analyzed on a fluorescence activated 
cell sorter (FACS II, Becton, Dickinson & Co., Mountain View, Calif.). Light-scatter criteria 
were used to gate on viable cells. 
In some experiments, a separate aliquot of erythrocyte-depleted spleen cells was analyzed for 
cytoplasmic IgM after fixation in a  5% acetic acid, 95% ethanol solution at -20°C, washed, 
and stained with F1 anti-#. Gating in this case was on all cells. 
Direct Coombs' Assay ofAnti-E~ythrocyte Autoantibodies.  Blood from each mouse was collected in 
preservative-free heparin and centrifuged at 10,000 g for 5 min. The erythrocytes were washed 
three times with phosphate-buffered saline, pH 7.2, and resuspended at a final concentration 
of 1%. Polyvalent sheep-anti-mouse-Ig  serum was heated at 56°C for 30 min and absorbed with 
an equal volume of packed mouse erythrocytes overnight at 4°C. The direct Coombs' assay was 
performed by adding to microtiter wells, 25 #1 of 1% erythrocyte suspension and 25 #1 of serial 
twofold dilutions of sheep anti-mouse Ig. The wells were then examined for agglutination after 
an incubation of 1 h at 37°C. A positive result was assigned to erythrocyte samples that showed 
agglutination  at a serum dilution of 1:40. Known positive and negative controls were performed 
with each assay. 
Statistical Methods.  Geometric means and standard errors were calculated from the results of 
the IgM secretion and reverse  plaque experiments. Comparisons were made by a  two-tailed 
Student's t test. Chi-square and Student's t test were applied to the results of the direct Coombs' 
assay. 
Results 
Antibody  Response  to  T-Independent  Antigens.  Castrated  mice  of eight  strains  and 
crosses were injected with rI.rC and bled 4  d  later. In Fig.  1, the results of the assay 
for antibodies to rI.rC in the serum of these mice are shown. The male mice bearing 
only the CBA/N X  chromosome (CBA/N, CBA/N  ×  NZB, and CBA/N  ×  DBA/2) 
all failed to make a significant antibody response, although all of the mice bearing at 
least one normal X  chromosome made a  significant response. In particular, both the 34  CBA/N  X-LINKED DEFECT  PREVENTS  NZB  B-CELL  HYPERACTIVITY 
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Flo.  1.  Antibody  response to  polyinosinic.polycytidylic  acid  in  mice  of different  strains  and 
crosses.  Mice were immunized with 100 #g of rl.rC and bled 4 d  later. The percentage of []4C]rI. 
rC bound by 50 p.l of serum (100%  is 28  ng) was assayed. Each bar with error bracket represents 
arithmetic mean  :!:  SEM of four or five mice, 7-12 wk of age. 
NZB  ×  CBA/N males and CBA/N  ×  NZB females, which differed from the CBA/ 
N  ×  NZB males only in their sex chromosomes, had normal responses. 
Similarly, castrated NZB, CBA/N, CBA/N  ×  NZB, NZB  ×  CBA/N, and CBA/ 
N  ×  DBA/2 male mice, aged  12-17 wk, each were injected with 0.5 #g of SIII; 5 d 
later, each spleen was assayed for the direct PFC response to SIII-coated SRBC. None 
of the mice bearing only a CBA/N X  chromosome made a detectable net response to 
SIII; the NZB and NZB  ×  CBA/N males made large responses (data not shown). 
IgM Secretion In  Vitro.  Spleen cells  from castrated  mice of different strains  and 
crosses were incubated in vitro for 4 h and their spontaneous secretion of IgM assayed. 
The results, summarized in Fig.  2, indicate that spleen cells of mice bearing only a 
CBA/N  X  chromosome secreted negligible amounts  of IgM  (P <0.001,  compared 
with  CBA/J).  NZB spleen cells secreted  10 times more IgM  than  those of CBA/J 
mice  (P <0.001).  Spleen  cells  of NZB  hybrids  with  at  least  one  non-CBA/N  X 
chromosome  secreted  quantities  of IgM  intermediate  between  those  of NZB  and 
CBA/J mice, and significantly different from each (P <0.001). 
The CBA/N  ×  NZB  male spleen cells secreted no more IgM  than did those of 
either CIBA/N or CBA/N  ×  DBA/2  males.  In  contrast,  the  IgM  secretion of the 
CBA/N  ×  NZB female and NZB  ×  CBA/N male spleen cells was comparable to 
that of other NZB F1 hybrids. 
Subclass-Specific Ig Production.  Spleen cells from castrated mice of different strains 
and crosses were assayed for production ofIgM, IgG1, and IgG2, and IgA by a reverse 
hemolytic-plaque technique. The results of the IgM-producing-cell assay are shown 
in  Fig.  3.  CBA/N,  CBA/N  ×  NZB  and  CBA/N  ×  DBA/2  male  spleens  had 
significantly fewer IgM-producing cells per 106 spleen cells than did spleens of CBA/ 
J  males or NZB F] hybrids with at least one normal X  chromosome (P <0.001). NZB 
male spleens had significantly more IgM-producing cells than did all other groups 
(P <0.001).  Because CBA/N,  CBA/N  ×  NZB, and  CBA/N  ×  DBA/2  males had TAUROG,  MOUTSOPOULOS,  ROSENBERG, CHUSED, AND STEINBERG 
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Fro.  2.  Secretion of IgM during 4 h, in vitro, by spleen cells from mice of different strains and 
crosses. Each bar with error bracket represents the geometric  mean :t: SEM of values from 8 to 15 
mice, 7-11 wk of age. 
reduced  numbers  of spleen  cells,  their  total  IgM-producing  cells  per  spleen  were 
proportionally even further reduced  (data not shown). 
The results of the IgGl-, IgG2- and IgA-producing cell assays are summarized in 
Fig.  4.  The number of IgGl-producing cells per  106 cells  (Fig.  4A)  of CBA/N and 
CBA/N  ×  NZB male spleens were similar to each other and significantly (P <0.001) 
less than the corresponding number of IgGl-producing cells of the NZB and control 
NZB Fx hybrid male spleens. However, the number of CBA/N and CBA/N  X  NZB 
male IgGl-producing cells were not significantly different (P >0.10) from those of the 
CBA/J males. The results of the IgG2-producing-cell assay (Fig. 4 B) were similar to 
those of the IgG 1 assay. CBA/N and CBA/N  ×  NZB males were low and NZB males 
were high. However, there was overlap of the control NZB Fz hybrid values with the 
CBA/J, CBA/N, and CBA/N  ×  NZB values. The IgG2-producing cells of all groups 
tended  to  be  more  numerous  than  those  producing  IgG1;  this  phenomenon  has 
previously been observed to be due to nonspeeifie environmental effeetsfl The number 
of IgA-produeing cells per 106 spleen cells were similar in all of the mice studied (Fig. 
4C). 
Flow  Microfluoromet~y.  Surface-membrane-Ig  staining  patterns  of  spleen  cells 
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Fro.  3.  Total  IgM  plaque-forming cells  per  10  6 spleen cells  from mice of different  strains and 
crosses. Each bar with error bracket represents geometric mean +  SEM of values from 4 to 12 mice, 
7-11  wk of age. 
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Fzc.  4.  Total  subclass-specific plaque-forming cells  per  10  ~ spleen cells  from  mice  of different 
strains  and  crosses;  (A)  IgG1,  (B)  IgG2,  and  ((2) IgA.  Each  bar  with  error bracket  represents 
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FIG.  5.  Fluorescence profiles of spleen cells  labeled with FI anti-Fab from (A) CBA/J male,  (B) 
CBA/N and NZB male, (C) CBA/N ×  NZB and NZB  x  CBA/N males, and (D) CBA/N  ×  NZB 
female  and  CBA/J  X  NZB  male  mice,  8-11  wk  old.  The area  under the  CBA/J  curve  is  not 
normalized with respect to the others. 
treated with F1  anti-Fab are shown in Fig. 5. The fluorescence-intensity distribution 
of cells from a  CBA/J mouse, shown in Fig.  5 A, illustrates that of a  normal strain. 
The CBA/N pattern  (Fig. 5 B) shows relatively fewer dull (less-intensely fluorescent) 
cells.  In  contrast,  NZB  spleen cells had  an  increased proportion of these dull cells 
(Fig. 5 B). The CBA/N  X  NZB male pattern (Fig. 5 C) did not differ from that of the 
CBA/N male, whereas the pattern of the NZB  X  CBA/N male spleen cells closely 
resembled that of the NZB spleen cells (Fig. 5 C). CBA/N  ×  NZB female and CBA/ 
J  x  NZB male spleen cells (Fig. 5 D), had  fluorescence-intensity distributions with 
Fl-anti-Fab staining similar to that of NZB, and NZB  X  CBA/N, males. 
Surface-membrane-Ig staining patterns of spleen cells treated with fluoresceinated 
anti-/~ are shown in Fig. 6. Again, the CBA/J pattern, shown in 6 A, illustrates that of 
a normal strain. The CBA/N pattern shows a relative deficiency of dull cells and an 
excess of bright cells, whereas the NZB pattern is similar to that of the CBA/J (Fig. 
6B). The CBA/N  X  NZB  male pattern is similar to that  of the CBA/N  (Fig. 6C) 
although the NZB  ×  CBA/N  males  (Fig. 6C)  CBA/J  X  NZB male, and CBA/N 
×  NZB female (Fig. 6 D) patterns, like the NZB pattern, are normal. 
Results of cytoplasmic staining of fixed spleen cells with fluoresceinated anti-/x are 
shown in Table I. Both CBA/N and CBA/N  ×  NZB males had significantly fewer 
positive cells than did CBA/J males (P <0.001), whereas NZB  X  CBA/N males had 
significantly more IgM-containing spleen cells than did CBA/J males (P <0.001). 38 
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Fro.  6.  Fluorescence profiles of spleen cells  labeled with F1  anti-# from  (A)  CBA/J  male,  (B) 
CBA/N and NZB male, (C) CBA/N x  NZB and NZB ×  CBA/N male, and (D) CBA/N X  NZB 
female and CBA/J  ×  NZB  male mice, 8-11  wk old.  The area  under the CBA/J curve is  not 
normalized with respect to the others. 
TABLE  I 
Fraction o/Spleen Cells Positive/or Cytoplasmic IgM by Flow Microfluorometry 
Number of  Percentage positive for  Strain  mice  IgM, mean ±  SEM 
P value 
Comparison  Comparison 
with CBA/N  with CBA/J 
% 
CBA/N  3  0.11  ±  0.02  --  <0.001 
CBA/N  ×  NZB  5  0.18  :!: 0.03  0.10  <0.001 
NZB  ×  CBA/N  8  1.70 +  0.07  <0.001  <0.001 
CBA/J  5  0.81  ±  0.06  <0.001  -- 
Spleen cells were fixed, then stained with FI anti-#, and analyzed by flow microfluorometry. Positive cells 
contained cytoplasmic IgM. All mice were males. 
Effect of Castration.  15 3-wk-old C3H/HeN  ×  NZB  males were divided into three 
equal  groups:  castrated,  sham-castrated,  and  intact.  The  mice  were  caged  together 
and  at  age  8  wk,  their  spleen  cells  were  assayed  for  IgM  secretion  in  vitro.  The 
geometric means  (+  SEM)  were, respectively,  162  (154-170);  156 (144-169);  and  152 
(135-170)  ng/107  cells/4  h,  for  castrated;  sham-castrated;  and  intact  mice.  These 
values are not statistically different. TAUROG, MOUTSOPOULOS, ROSENBERG, CHUSED, AND STEINBERG 
TABLE  II 
Direct Coombs' Test in 9-mo-oM CBA/N ×  NZB Mice 
39 
Number of  Number posi-  Mean titer ± 
Strain  tive (titer  mice  SEM  1:40) 
CBA/N ×  NZB, females  22  10  3.54 ± 0.90 
CBA/N × NZB, males  20  2*:]:  0.95 ± 0.68§ 
CBA/N ×  NZB, castrated males  17  0~  0.00 ± 0.00~ 
* These two mice, unlike any of the females tested, showed hemolysis, rather than aggluti- 
nation, of erythrocytes, that may represent a false-positive result. 
:~ P <  0.05, compared with females, by chi-square analysis. 
§ P <  0.05, compared with females, by Student's t test. 
Similarly, no significant differences occurred in the antibody responses of castrated, 
sham-castrated, and intact BALB/c  ×  NZB males 4 d after immunization with  100 
#g rI-rC in saline. 
Anti-E~ythrocyte  Antibodies in Older  CBA/N  ×  NZB Mice.  9-m-old CBA/N  ×  NZB 
mice were studied  for the presence of anti-erythrocyte autoantibodies by the direct 
Coomb's method. The results, presented in Table II, show that  both castrated and 
intact CBA/N  ×  NZB males had significantly less anti-erythrocyte autoantibody on 
their erythrocytes than did comparably aged, intact CBA/N  ×  NZB females. 
Discussion 
In this study we have analyzed, by a  variety of techniques, the B-cell properties 
and  functions of CBA/N  ×  NZB F1 male mice and mice of several control strains 
and crosses. We have examined, in one series of experiments, most of the immune 
properties that  characterize the X-linked genetic deficiency of CBA/N mice. In all 
experiments, there was agreement among the various assays and techniques employed: 
NZB  mice have excessive numbers  of splenic  IgM-producing cells,  excessive total- 
splenic-IgM production, vigorous immune responses to two T-independent antigens, 
and  an  increase in  splenic  B  cells bearing a  low proportion of total surface Ig.  In 
contrast, CBA/N mice are deficient in total splenic-IgM production, in IgM response 
to two T-independent antigens, in numbers of splenic IgM-producing cells (by both 
reverse  plaque  analysis  and  cytoplasmic  fluorescent  staining),  and  in  spleen  cells 
bearing  small  quantities  of surface-membrane  IgM.  Furthermore,  the  CBA/N  X- 
linked defect of B-lymphocyte function is fully expressed in CBA/N  ×  NZB Fa male 
mice. These hybrids closely resemble homozygous CBA/N mice and control hemizy- 
gous CBA/N  ×  DBA/2 male mice in:  (a) failure to make antibody responses to two 
T-independent antigens,  (b) reduced numbers of total splenic IgM-secreting cells, (c) 
barely detectable in vitro secretion of IgM, and (d)  cell-surface-Ig characteristics. In 
contrast, NZB  X  CBA/N  males  and  CBA/N  X  NZB  females, which  lack the X- 
linked defect, resemble the other NZB F1 hybrids studied. Thus, despite the excessive 
B-cell activity of NZB mice, the CBA/N X-chromosome has the same influence on 
the splenic B cells of a CBA/N  X  NZB Fi hybrid male as on those of a  CBA/N  X 
DBA/2 or any other previously reported, CBA/N-mothered F1 hybrid male mouse. 
It  is  remarkable  that  the  CBA/N  X  NZB  Fa  male  B-cell  functions  were  not 
different from those of the CBA/N males. One might have predicted that the CBA/ 40  CBA/N  X-LINKED DEFECT PREVENTS NZB B-CELL HYPERACTIVITY 
N  ×  NZB males would have greater spleen cell IgM secretion and greater numbers 
of splenic  IgM-producing cells than  CBA/N  males on  the basis of an effect of the 
NZB genes upon those B cells not  affected by the CBA/N X-chromosone-mediated 
defect.  The  observed  results  suggest  that,  with  regard  to  abnormalities  of  IgM 
production, the NZB genetic defect acts almost exclusively upon that subset of B cells 
upon  which  the  X-linked  CBA/N  defect  acts.  Further  work  is  required  to  assign 
relative positions to the CBA/N and NZB genetic influences in the pathway of B-cell 
differentiation and proliferation. 
In contrast to the markedly reduced numbers of IgM-producing cells, the numbers 
of IgGl-producing spleen cells of the CBA/N-mothered males studied  were compa- 
rable to those of the normal CBA/J mice. However, their IgGl-producing cells were 
lower than those of the NZB F1 hybrids possessing at least one normal X  chromosome. 
These results raise the possibility of a  minor effect of the CBA/N X  chromosome on 
the  high  IgG1  production  of NZB  mice and  their  F1  hybrids.  IgA-producing cells 
were numerically similar in all mice studied, suggesting that neither the B-cell defect 
of the CBA/N strain nor the B-cell hyperresponsiveness of the NZB strain influences 
spleen cell IgA production. 
Considerable  evidence  has  accumulated  to  support  a  prominent  role  for  sex 
hormones  in  the  expression  of autoimmunity  in  F1  hybrids  of NZB  mice  (37-40). 
Therefore, the mice used in the present study were castrated to eliminate potential 
effects  of  sex  hormones  on  the  functions  under  investigation.  We  thought  this 
particularly important in a study of CBA/N hybrids with immune responses known 
to be influenced  by a  sex chromosome. Nonetheless,  prepubertal  castration  had  no 
effect upon in vitro IgM production by sp!een cells ofC3H  ×  NZB males, nor on the 
4-d IgM antibody response to the T-independent antigen rI.rC in BALB/c  ×  NZB 
males.  These  data  suggest  that  castration  had  neither  a  positive  nor  a  negative 
influence  on  those  B-cell  functions  profoundly  suppressed  by  the  presence  of the 
CBA/N X  chromosome. 
Uncertainty exists regarding the relative importance of B cells and T  cells in the 
expression of autoimmunity in New Zealand mice. The finding that B cells appear to 
be  excessively activated  very early  in  life  in  NZB  mice  and  their  F1  hybrids  has 
suggested a  primary role for the B cell  (10,  12,  22,  28).  However, T-cell defects also 
occur  in  NZB  mice.  In  particular,  defects  in  NZB  suppressor-T-cell  function  not 
specific for antigen occur by 4 wk of age (24), a time when NZB B-cell excesses have 
not  reached  their  peak  (11).  Studies  of tolerance  to  heterologous  gamma globulin 
suggest that both B cells and T  cells may contribute to the observed defects (17).  Both 
B-cell (27) and T-cell (26)  abnormalities have been observed in the spontaneous anti- 
erythrocyte production  of NZB mice. However, little is known of the specific inter- 
action  of T  and  B  cells required  for the production  of these autoantibodies;  less is 
known  about T- and  B-cell abnormalities leading  to other autoantibody responses. 
The  excessive  IgM  produced  by  NZB  mice  is  known  to  be polyclonal,  without  a 
preponderance of specific autoantibody (11). Castration, which profoundly accelerates 
autoimmunity  in  NZB  hybrids  (37-39),  had  no  short-term  effect  on  total  IgM 
secretion or the IgM response to rI.rC.  Nevertheless, it is reasonable to assume that 
the excessive IgM production observed in short-term NZB-spleen-cell cultures bears 
an important  relationship  to high serum  IgM levels (1 l)  and  to IgM-autoantibody 
production  (44)  in  NZB mice. Our preliminary studies of the spontaneous develop- 
ment  of anti-erythrocyte autoantibodies  indicate  that  CBA/N  ×  NZB  males have TAUROG, MOUTSOPOULOS, ROSENBERG, CHUSED, AND STEINBERG  41 
retarded development of this a.utoantibody relative to their female littermates. This 
observation suggests that the CBA/N X-linked gene is capable of favorably modifying 
the spontaneous expression of autoimmunity. Whether or not the same effects will be 
observed in  NZB  mice will  be learned  from studies  of congenic mice bearing the 
CBA/N X  chromosome on an NZB background. 
Different spontaneously-produced autoantibodies of New Zealand mice have been 
shown to be under separate, although complex, genetic control (4,  7, 45). Whether 
such  genetic control  involves one subset  of lymphocytes, such  as  B  cells,  remains 
unknown. However, we have found in the present study that the genetically condi- 
tioned, high IgM, B-cell response of NZB mice may be modified by the CBA/N X- 
linked  gene in such  a  way as  to completely abrogate the effect of the  NZB  genes. 
Further studies are in progress to determine the effects of the CBA/N X-linked defect 
upon the development of autoimmunity in NZB mice. We hope that such studies will 
serve to further clarify the role ofT-independent immune responses in the development 
of spontaneous autoimmunity. 
Summary 
NZB mice and  their Fa hybrids produce excessive polyclonal IgM and  autoanti- 
bodies of both IgM and IgG classes.  CBA/N mice and CBA/N-mothered F1 males 
fail to make antibody to many T-independent antigens and have low levels of serum 
IgM;  further, these mice lack a population of splenic B cells characterized by a low- 
to-intermediate density of surface IgM. We have studied male CBA/N, NZB, CBA/ 
N  X  NZB, NZB  ×  CBA/N, and CBA/J mice; female CBA/N  ×  NZB mice; and 
males of several control crosses of NZB and CBA/N mice. We have found that the 
CBA/N X-linked defect of T-independent immune response is completely expressed 
in CBA/N  ×  NZB mice. In marked contrast to NZB mice and to NZB Fa hybrids 
bearing  at  least  one normal  X  chromosome, the  CBA/N  ×  NZB  males  failed to 
respond to two T-independent antigens, had small numbers of splenic IgM-producing 
cells, barely detectable splenic IgM production, and splenic B-cell surface-Ig patterns 
resembling those of CBA/N mice. These data suggest that the NZB B-cell abnormality 
resulting in excessive IgM production occurs almost exclusively in that population of 
B  cells  affected by  the  CBA/N  X-chromosome-linked defect.  Preliminary  studies 
suggest that the CBA/N X chromosome retards the spontaneous development of anti- 
erythrocyte autoantibodies in CBA/N  ×  NZB males. Castration, known to accelerate 
autoimmune disease in certain NZB F1 males, appears to have no influence on the 
immune functions examined in this study. 
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